Can a common diabetes drug be used safely in kidney failure? new study investigates

NCT ID NCT02710448

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looked at whether the diabetes drug metformin can be used safely in people with type 2 diabetes who also have kidney disease. Researchers gave increasing doses of metformin to 82 patients with different stages of kidney failure and measured the drug levels in their red blood cells. The goal was to see if these levels stayed within a safe range, which could help guide future use of metformin in this population.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Metformin
What this could lead to
If successful, this could help doctors safely prescribe metformin to diabetic patients with kidney disease, expanding treatment options.
What could go wrong
This is a small, early-phase study focused on safety monitoring, not on proving effectiveness. Results may not change current medical guidelines.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Service d'Endocrinologie, Maladies Métaboliques et Nutrition

    Amiens, 80054, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.